查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1638784

氧化压力测定市场机会、成长动力、产业趋势分析与预测 2024 - 2032

Oxidative Stress Assay Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 142 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023 年，全球氧化压力检测市场价值为 11 亿美元，预计 2024 年至 2032氧化压力复合年增长率为 9.8%。的实验室测试。透过评估活性氧 (ROS) 和抗氧化剂之间的平衡，它们为氧化压力引起的细胞和组织损伤提供了宝贵的见解。

市场分为两大类：仪器和消耗品。在消耗品领域，检测试剂盒和试剂预计将显着成长，预计到2032 年该领域将达到15 亿美元。一致性结果，使不同专业水平的实验室都可以轻鬆获得它们。这种易用性和可靠性正在推动整个市场的更广泛采用。

根据检测类型，2023 年间接检测领域的市场价值为 4.661 亿美元。其简单的程序有助于最大限度地减少错误并加快测试过程，使其成为研究和临床实验室常规使用的理想选择。

市场范围
开始年份 2023年
预测年份 2024-2032
起始值 11亿美元
预测值 25亿美元
复合年增长率 9.8%

到 2032 年，美国氧化压力检测产业预计将成长至 9.217 亿美元。此外，美国市场受益于强大的监管环境，并受到食品药物管理局 (FDA) 等机构的监督。该法规确保氧化压力测定符合严格的安全性和准确性标准，增强消费者的信任并鼓励市场进一步成长。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 慢性病盛行率增加
      • 诊断技术的进步
      • 提高抗氧化疗法的认识
      • 药物发现和开发研究不断增加
    • 产业陷阱与挑战
      • 仪器成本高
      • 严格的监管挑战
  • 成长潜力分析
  • 监管环境
  • 技术景观
    • 核心技术
    • 邻近技术
  • 未来市场趋势
  • 差距分析
  • 波特的分析
  • PESTEL分析

第 4 章：竞争格局

  • 介绍
  • 公司市占率分析
  • 公司矩阵分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 战略仪表板

第 5 章：市场估计与预测：按产品分类，2021 - 2032 年

  • 主要趋势
  • 仪器仪表
  • 耗材
    • 套件
    • 试剂

第 6 章：市场估计与预测：按类型，2021 - 2032

  • 主要趋势
  • 间接测定
    • 基于蛋白质的检测
    • 基于脂质的测定
    • 基于核酸的检测
  • 抗氧化能力测定
    • 谷胱甘肽测定
    • 抗坏血酸测定
    • 基于细胞的外源性抗氧化剂测定
  • 基于酵素的测定
  • 基于活性氧的测定

第 7 章：市场估计与预测：按技术分类，2021 - 2032

  • 主要趋势
  • 酵素连结免疫吸附测定法 (ELISA)
  • 流式细胞仪
  • 色谱法
  • 显微镜检查
  • 其他技术

第 8 章：市场估计与预测：按疾病类型，2021 - 2032

  • 主要趋势
  • 心血管疾病
  • 呼吸系统疾病
  • 癌症
  • 糖尿病
  • 其他疾病

第 9 章：市场估计与预测：按最终用途，2021 - 2032 年

  • 主要趋势
  • 製药和生物技术产业
  • 学术研究机构
  • 合约研究组织 (CRO)
  • 临床实验室
  • 其他最终用户

第 10 章：市场估计与预测：按地区，2021 - 2032

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第 11 章：公司简介

  • AMSBIO
  • ABCAM
  • Agilent Technologies
  • Biorbyt
  • Cayman Chemical
  • Cell Biolabs
  • Dojindo Molecular Technologies
  • Enzo Biochem
  • GenScript Biotech Corporation
  • LifeSpan BioSciences
  • Merck
  • Promega Corporation
  • QIAGEN
  • RayBiotech
  • Thermo Fisher Scientific
简介目录
Product Code: 12150

The Global Oxidative Stress Assay Market was valued at USD 1.1 billion in 2023 and is projected to grow at 9.8% CAGR from 2024 to 2032. These assays are laboratory tests utilized to evaluate oxidative stress biomarkers in samples like blood, urine, or tissue. By assessing the balance between reactive oxygen species (ROS) and antioxidants, they offer valuable insights into cellular and tissue damage caused by oxidative stress.

The market is segmented into two main categories: instruments and consumables. Within the consumables segment, assay kits and reagents are expected to see significant growth, with the segment projected to reach USD 1.5 billion by 2032. Pre-packaged consumables, such as ready-to-use kits and reagents, simplify assay workflows and ensure consistency in results, making them highly accessible for laboratories across various expertise levels. This ease of use and reliability is driving broader adoption across the market.

Based on assay type, the market from the indirect assays segment was valued at USD 466.1 million in 2023. These assays are favored for their simplicity and user-friendliness, making them an attractive option for both researchers and clinicians. Their straightforward procedures help minimize errors and speed up the testing process, making them ideal for routine use in research and clinical laboratories.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$1.1 Billion
Forecast Value$2.5 Billion
CAGR9.8%

The U.S. oxidative stress assay industry is expected to grow to USD 921.7 million by 2032. The increasing prevalence of chronic conditions, such as cardiovascular diseases, diabetes, and cancer, is driving the demand for effective diagnostic and therapeutic solutions. Additionally, the U.S. market benefits from a strong regulatory environment, with oversight from agencies such as the Food and Drug Administration (FDA). This regulation ensures that oxidative stress assays meet stringent safety and accuracy standards, boosting consumer trust and encouraging further market growth.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of chronic diseases
      • 3.2.1.2 Advances in diagnostic technologies
      • 3.2.1.3 Increasing awareness of antioxidant therapies
      • 3.2.1.4 Rising research in drug discovery and development
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost of instruments
      • 3.2.2.2 Stringent regulatory challenges
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technology landscape
    • 3.5.1 Core technologies
    • 3.5.2 Adjacent technologies
  • 3.6 Future market trends
  • 3.7 Gap analysis
  • 3.8 Porter's analysis
  • 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Instruments
  • 5.3 Consumables
    • 5.3.1 Kits
    • 5.3.2 Reagents

Chapter 6 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Indirect assays
    • 6.2.1 Protein-based assays
    • 6.2.2 Lipid-based assays
    • 6.2.3 Nucleic acid-based assays
  • 6.3 Antioxidant capacity assays
    • 6.3.1 Glutathione assays
    • 6.3.2 Ascorbic acid assays
    • 6.3.3 Cell-based exogenous antioxidant assays
  • 6.4 Enzyme-based assays
  • 6.5 Reactive oxygen species-based assays

Chapter 7 Market Estimates and Forecast, By Technology, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Enzyme-Linked Immunosorbent Assay (ELISA)
  • 7.3 Flow cytometry
  • 7.4 Chromatography
  • 7.5 Microscopy
  • 7.6 Other technologies

Chapter 8 Market Estimates and Forecast, By Disease Type, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Cardiovascular disease
  • 8.3 Respiratory diseases
  • 8.4 Cancer
  • 8.5 Diabetes
  • 8.6 Other diseases

Chapter 9 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 Pharmaceutical and biotechnology industries
  • 9.3 Academic research institutes
  • 9.4 Contract Research Organizations (CROs)
  • 9.5 Clinical laboratories
  • 9.6 Other end users

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 10.1 Key trends
  • 10.2 North America
    • 10.2.1 U.S.
    • 10.2.2 Canada
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 France
    • 10.3.4 Spain
    • 10.3.5 Italy
    • 10.3.6 Netherlands
  • 10.4 Asia Pacific
    • 10.4.1 China
    • 10.4.2 Japan
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 South Korea
  • 10.5 Latin America
    • 10.5.1 Brazil
    • 10.5.2 Mexico
    • 10.5.3 Argentina
  • 10.6 Middle East and Africa
    • 10.6.1 South Africa
    • 10.6.2 Saudi Arabia
    • 10.6.3 UAE

Chapter 11 Company Profiles

  • 11.1 AMSBIO
  • 11.2 ABCAM
  • 11.3 Agilent Technologies
  • 11.4 Biorbyt
  • 11.5 Cayman Chemical
  • 11.6 Cell Biolabs
  • 11.7 Dojindo Molecular Technologies
  • 11.8 Enzo Biochem
  • 11.9 GenScript Biotech Corporation
  • 11.10 LifeSpan BioSciences
  • 11.11 Merck
  • 11.12 Promega Corporation
  • 11.13 QIAGEN
  • 11.14 RayBiotech
  • 11.15 Thermo Fisher Scientific